Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:BVS NYSE:INSP NASDAQ:LMAT NASDAQ:LQDA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBVSBioventus$6.93-3.8%$6.95$5.81▼$14.38$572.97M0.84395,680 shs548,436 shsINSPInspire Medical Systems$79.86-4.2%$99.65$73.92▼$218.52$2.47B1.15949,388 shs1.64 million shsLMATLeMaitre Vascular$92.25-1.3%$90.52$71.42▼$109.58$2.11B0.79155,007 shs752,444 shsLQDALiquidia Technologies$23.78-3.6%$23.11$9.71▼$29.94$2.12B0.222.13 million shs4.38 million shsThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBVSBioventus-3.75%-4.15%-3.88%+5.80%-40.72%INSPInspire Medical Systems-4.31%-0.52%-14.18%-38.93%-61.64%LMATLeMaitre Vascular-1.25%-0.04%-4.61%+12.80%+3.83%LQDALiquidia Technologies-3.61%-8.50%-13.05%+80.56%+139.96%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBVSBioventus$6.93-3.8%$6.95$5.81▼$14.38$572.97M0.84395,680 shs548,436 shsINSPInspire Medical Systems$79.86-4.2%$99.65$73.92▼$218.52$2.47B1.15949,388 shs1.64 million shsLMATLeMaitre Vascular$92.25-1.3%$90.52$71.42▼$109.58$2.11B0.79155,007 shs752,444 shsLQDALiquidia Technologies$23.78-3.6%$23.11$9.71▼$29.94$2.12B0.222.13 million shs4.38 million shsThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBVSBioventus-3.75%-4.15%-3.88%+5.80%-40.72%INSPInspire Medical Systems-4.31%-0.52%-14.18%-38.93%-61.64%LMATLeMaitre Vascular-1.25%-0.04%-4.61%+12.80%+3.83%LQDALiquidia Technologies-3.61%-8.50%-13.05%+80.56%+139.96%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBVSBioventus 2.75Moderate Buy$13.7598.41% UpsideINSPInspire Medical Systems 2.57Moderate Buy$164.50105.99% UpsideLMATLeMaitre Vascular 2.40Hold$97.605.80% UpsideLQDALiquidia Technologies 3.00Buy$32.1135.03% UpsideCurrent Analyst Ratings BreakdownLatest BVS, INSP, LQDA, and LMAT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/2/2025INSPInspire Medical SystemsEvercore ISISubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageOutperform$150.008/15/2025INSPInspire Medical SystemsLeerink PartnersSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetMarket Perform$116.00 ➝ $97.008/15/2025LQDALiquidia TechnologiesJefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$43.008/13/2025LQDALiquidia TechnologiesRaymond James FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetStrong-Buy$33.00 ➝ $41.008/13/2025LQDALiquidia TechnologiesWells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$25.00 ➝ $31.008/12/2025LQDALiquidia TechnologiesNeedham & Company LLCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$32.00 ➝ $36.008/6/2025LMATLeMaitre VascularCantor FitzgeraldSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$92.00 ➝ $95.008/6/2025LMATLeMaitre VascularBarrington ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeMarket Perform ➝ Outperform$95.008/5/2025INSPInspire Medical SystemsLake Street CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetBuy$270.00 ➝ $150.008/5/2025INSPInspire Medical SystemsWells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetEqual Weight$174.00 ➝ $101.008/5/2025INSPInspire Medical SystemsUBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetBuy$270.00 ➝ $230.00(Data available from 9/20/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBVSBioventus$564.14M1.02$0.55 per share12.58$2.80 per share2.48INSPInspire Medical Systems$802.80M2.94$1.64 per share48.81$23.01 per share3.47LMATLeMaitre Vascular$219.86M9.50$2.36 per share39.11$15.00 per share6.15LQDALiquidia Technologies$14M146.23N/AN/A$0.91 per share26.13Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBVSBioventus-$156.23MN/AN/A15.07N/A-7.11%15.61%4.01%N/AINSPInspire Medical Systems$53.51M$1.7346.1624.802.606.17%10.38%8.93%11/3/2025 (Estimated)LMATLeMaitre Vascular$44.04M$2.0644.7842.512.4020.08%13.67%9.14%10/30/2025 (Estimated)LQDALiquidia Technologies-$130.39M-$1.70N/AN/AN/A-732.17%-232.96%-60.81%11/12/2025 (Estimated)Latest BVS, INSP, LQDA, and LMAT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/12/2025Q2 2025LQDALiquidia Technologies-$0.43-$0.49-$0.06-$0.49$3.90 million$8.84 million8/5/2025Q2 2025LMATLeMaitre Vascular$0.57$0.60+$0.03$0.60$62.48 million$63.15 million8/4/2025Q2 2025INSPInspire Medical Systems$0.22$0.45+$0.23-$0.12$214.50 million$217.09 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBVSBioventusN/AN/AN/AN/AN/AINSPInspire Medical SystemsN/AN/AN/AN/AN/ALMATLeMaitre Vascular$0.800.87%N/A38.83%14 YearsLQDALiquidia TechnologiesN/AN/AN/AN/AN/ALatest BVS, INSP, LQDA, and LMAT DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date7/30/2025LMATLeMaitre Vascularquarterly$0.200.9%8/21/20258/21/20259/4/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBVSBioventus1.851.410.99INSPInspire Medical SystemsN/A6.144.84LMATLeMaitre Vascular0.4613.9611.74LQDALiquidia Technologies9.842.492.41Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBVSBioventus62.94%INSPInspire Medical Systems94.91%LMATLeMaitre Vascular84.64%LQDALiquidia Technologies64.54%Insider OwnershipCompanyInsider OwnershipBVSBioventus33.00%INSPInspire Medical Systems4.10%LMATLeMaitre Vascular9.50%LQDALiquidia Technologies26.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBVSBioventus1,20082.68 million54.46 millionNot OptionableINSPInspire Medical Systems1,24629.57 million28.36 millionOptionableLMATLeMaitre Vascular49022.64 million20.49 millionOptionableLQDALiquidia Technologies5086.09 million63.28 millionOptionableBVS, INSP, LQDA, and LMAT HeadlinesRecent News About These CompaniesRaman Singh Sells 45,524 Shares of Liquidia Technologies (NASDAQ:LQDA) StockSeptember 18 at 5:37 PM | marketbeat.comLiquidia Technologies (NASDAQ:LQDA) Director Raman Singh Sells 45,524 SharesSeptember 18 at 7:45 AM | insidertrades.comSapient Capital LLC Reduces Stake in Liquidia Technologies, Inc. $LQDASeptember 18 at 4:40 AM | marketbeat.comLiquidia Technologies, Inc. (NASDAQ:LQDA) Given Average Rating of "Buy" by BrokeragesSeptember 18 at 2:31 AM | americanbankingnews.comLiquidia Technologies, Inc. (NASDAQ:LQDA) Given Consensus Recommendation of "Buy" by BrokeragesSeptember 18 at 2:30 AM | marketbeat.comLiquidia Corporation (LQDA): A Bull Case Theory September 16, 2025 | insidermonkey.comBluefin Capital Management LLC Acquires Shares of 16,918 Liquidia Technologies, Inc. $LQDASeptember 12, 2025 | marketbeat.comLiquidia Announces Poster Presentations at the Pulmonary Hypertension Professional Association (PHPN) SymposiumSeptember 11, 2025 | markets.businessinsider.comAdage Capital Partners GP L.L.C. Purchases 376,872 Shares of Liquidia Technologies, Inc. $LQDASeptember 9, 2025 | marketbeat.comLiquidia Technologies (NASDAQ:LQDA) Director Sells $220,650.00 in StockSeptember 6, 2025 | insidertrades.comLiquidia Technologies, Inc. $LQDA Shares Purchased by Boothbay Fund Management LLCSeptember 6, 2025 | marketbeat.comLiquidia Technologies (NASDAQ:LQDA) Director Sells $4,312,175.78 in StockSeptember 4, 2025 | marketbeat.comLiquidia Technologies (NASDAQ:LQDA) Director Sells $5,198,967.84 in StockSeptember 4, 2025 | marketbeat.comLiquidia Technologies (NASDAQ:LQDA) Director Paul Manning Sells 328,268 SharesSeptember 4, 2025 | marketbeat.comInsider Selling: Liquidia Technologies (NASDAQ:LQDA) Insider Sells 451 Shares of StockSeptember 4, 2025 | marketbeat.comInsider Selling: Liquidia Technologies (NASDAQ:LQDA) Insider Sells 20,000 Shares of StockSeptember 4, 2025 | marketbeat.comLiquidia Technologies (NASDAQ:LQDA) Insider Jason Adair Sells 26,057 SharesSeptember 4, 2025 | marketbeat.comLiquidia Technologies Target of Unusually High Options Trading (NASDAQ:LQDA)September 4, 2025 | marketbeat.comJefferies Highlights Yutrepia’s Market Edge in Supporting a Buy on Liquidia (LQDA)September 4, 2025 | msn.comLiquidia Technologies (NASDAQ:LQDA) Sets New 12-Month High - Here's WhySeptember 4, 2025 | marketbeat.comVestal Point Capital LP Has $18.10 Million Stock Holdings in Liquidia Technologies, Inc. $LQDASeptember 4, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeBVS, INSP, LQDA, and LMAT Company DescriptionsBioventus NYSE:BVS$6.93 -0.27 (-3.75%) Closing price 09/19/2025 04:00 PM EasternExtended Trading$6.75 -0.18 (-2.66%) As of 09/19/2025 06:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Bioventus Inc., a medical device company, focuses on developing and commercializing treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical pain injection therapies, as well as peripheral nerve stimulation products, such as Durolane, GELSYN-3, and SUPARTZ for the treatment of knee osteoarthritis and Stimrouter to treat chronic peripheral pain. Its surgical solutions comprise bone graft substitutes that increase bone formation to stimulate bone healing in spinal fusions and other orthopedic surgeries; and ultrasonic products used for precise bone cutting and sculpting, soft tissue management, and tissue debridement, in various surgeries, including minimally invasive applications. The company's product include, Osteoamp, an allograft-derived bone graft for bone grafting procedures; Exponent matrix for posterolateral spine procedures; Purebone for bone grafting procedures; Signafuse bone graft; Interfuse bone graft; Osteomatrix+ synthetic bone graft; Extractor for autologous cell and bone marrow extraction; reficio bone matrix; nexus ultrasonic surgical system; bonescalpel surgical solution; SonaStar for surgical procedures; and SonicOne ultrasonic cleansing and debridement system. The company's restorative therapies include a bone stimulation system and devices to help patients regain leg or hand function due to stroke, multiple sclerosis, or other central nervous system disorders. Its products include exogen, a bone healing system; L300 GO, a foot drop system; H200 rehabilitation system; Vector, a body weight support system; and Bioness integrated therapy system. It developing Talisman pulse generator and receiver for peripheral nerve stimulation. The company was founded in 2011 and is headquartered in Durham, North Carolina.Inspire Medical Systems NYSE:INSP$79.86 -3.54 (-4.24%) Closing price 09/19/2025 03:59 PM EasternExtended Trading$81.39 +1.53 (+1.92%) As of 09/19/2025 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.LeMaitre Vascular NASDAQ:LMAT$92.25 -1.17 (-1.25%) Closing price 09/19/2025 04:00 PM EasternExtended Trading$92.22 -0.03 (-0.03%) As of 09/19/2025 04:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature. The company also provides artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches, used for closure of vessels after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; cardiovascular patches; carotid shunts that temporarily shunt the blood to the brain during the removal of plaque in a carotid endarterectomy surgery; biosynthetic vascular graft indicated for lower extremity bypass and dialysis access; and vascular grafts used to bypass or replace diseased arteries. In addition, it offers radiopaque tape, a medical-grade tape applied to the skin that enables surgeons and interventionalists to cross-refer between the inside and the outside of a patient's body and allows them to locate tributaries or lesions beneath the skin. Further, the company provides valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.Liquidia Technologies NASDAQ:LQDA$23.78 -0.89 (-3.61%) Closing price 09/19/2025 04:00 PM EasternExtended Trading$23.84 +0.05 (+0.23%) As of 09/19/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company also offers Remodulin, a treprostinil administered through continuous intravenous and subcutaneous infusion. The company also a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas FedEx Delivers Good News: The Bottom Is in for This Stock Tesla: 2 Reasons to Love Musk's $1B Buy, 1 Reason to Be Bearish Berkshire-Backed Lennar Slides After Weak Q3 Earnings Azure Leads While AI Excitement Fuels Microsoft Stock Caterpillar Stock Hits All-Time High—Is There More Room to Run? The Fed Cut Rates: What Now for the S&P 500 and Equity Markets? Darden Restaurants: A Textbook Buy-the-Dip Opportunity McDonald’s: New All-Time Highs Are Inevitable Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
